Novel Acylguanidine-Based Inhibitor of HIV-1

The emergence of transmissible HIV-1 strains with resistance to antiretroviral drugs highlights a continual need for new therapies. Here we describe a novel acylguanidine-containing compound, 1-(2-(azepan-1-yl)nicotinoyl)guanidine (or SM111), that inhibits in vitro replication of HIV-1, including st...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Virol
Main Authors: Mwimanzi, Philip, Tietjen, Ian, Miller, Scott C., Shahid, Aniqa, Cobarrubias, Kyle, Kinloch, Natalie N., Baraki, Bemuluyigza, Richard, Jonathan, Finzi, Andrés, Fedida, David, Brumme, Zabrina L., Brockman, Mark A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2016
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5044834/
https://ncbi.nlm.nih.gov/pubmed/27512074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01107-16
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados